Clinical usefulness of ursodeoxycholic acid for Japanese patients with autoimmune hepatitis-Reference-Cited by-同舟云学术

Clinical usefulness of ursodeoxycholic acid for Japanese patients with autoimmune hepatitis

Published:2017 Issue:1 Volume:9 Page:57
ISSN:1948-5182
Container-title:World Journal of Hepatology
language:en
Short-container-title:WJH

Author:

Torisu Yuichi,Nakano Masanori,Takano Keiko,Nakagawa Ryo,Saeki Chisato,Hokari Atsushi,Ishikawa Tomohisa,Saruta Masayuki,Zeniya Mikio

Publisher

Baishideng Publishing Group Inc.

Subject

Hepatology

Reference28 articles.

1. Management of autoimmune hepatitis

2. EASL Clinical Practice Guidelines: Autoimmune hepatitis

3. Prednisone for chronic active liver disease: dose titration, standard dose, and combination with azathioprine compared.

4. Safety issues in the management of autoimmune hepatitis

5. Uribe M, Go VL, Kluge D. Prednisone for chronic active hepatitis: pharmacokinetics and serum binding in patients with chronic active hepatitis and steroid major side effects. J Clin Gastroenterol 1984;6:331-335.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Autoimmune hepatitis – an increasingly common cause of hypertransaminasaemia among children. Case report and literature review;Pediatria i Medycyna Rodzinna;2024-07-05

2. Pharmacokinetics and Pharmacodynamics of Ursodeoxycholic Acid in an Overweight Population With Abnormal Liver Function;Clinical Pharmacology in Drug Development;2020-03-19

3. Autoimmune Hepatitis—Immunologically Triggered Liver Pathogenesis—Diagnostic and Therapeutic Strategies;Journal of Immunology Research;2019-11-25

4. Pharmacokinetics of Ursodeoxycholic Acid in Elderly Volunteers Compared With Younger Adults in a Korean Population;The Journal of Clinical Pharmacology;2019-03-18

5. Autoimmune Hepatitis, Sclerosing Cholangitis, and Autoimmune Sclerosing Cholangitis or Overlap Syndrome;Clinics in Liver Disease;2018-11